Literature DB >> 2174371

The distribution of antibodies to HHV-6 compared with other herpesviruses in young children.

T J Farr1, G B Harnett, G R Pietroboni, M R Bucens.   

Abstract

Sera from 141 infants aged 0-12 months were examined for IgG antibodies to HHV-6, HSV, CMV, VZV and EBV and for HHV-6 specific IgM. Following the decline in maternal antibody, antibody to HHV-6 was found to rise by 5-6 months and approached the level found in adults by 11-12 months. In contrast the antibody rates for the other herpesviruses were much slower to rise, especially in the case of CMV and EBV. HHV-6 IgM antibodies were detected mainly in age groups showing a rapid rise in antibody to HHV-6. HHV-6-IgM was not detected in 235 cord blood samples. The data suggest that HHV-6 infection is acquired horizontally, at a very early age in Western Australia.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2174371      PMCID： PMC2271835          DOI： 10.1017/s095026880004824x

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN： 0950-2688            Impact factor:   2.451


  13 in total

1.  Characteristics of human herpesvirus-6.

Authors:  C Lopez; P Pellett; J Stewart; C Goldsmith; K Sanderlin; J Black; D Warfield; P Feorino
Journal:  J Infect Dis       Date:  1988-06       Impact factor: 5.226

2.  Seroconversion against human herpesvirus-6 (and other herpesviruses) and clinical illness.

Authors:  H Kirchesch; T Mertens; U Burkhardt; J P Kruppenbacher; A Höffken; H J Eggers
Journal:  Lancet       Date:  1988-07-30       Impact factor: 79.321

3.  Isolation of human herpesvirus 6 from saliva.

Authors:  G R Pietroboni; G B Harnett; M R Bucens; R W Honess
Journal:  Lancet       Date:  1988-05-07       Impact factor: 79.321

4.  A modified immunofluorescence test for Epstein-Barr virus-specific IgM antibody.

Authors:  G B Harnett; C A Palmer; M R Bucens
Journal:  J Virol Methods       Date:  1985-10       Impact factor: 2.014

5.  Frequent shedding of human herpesvirus 6 in saliva.

Authors:  G B Harnett; T J Farr; G R Pietroboni; M R Bucens
Journal:  J Med Virol       Date:  1990-02       Impact factor: 2.327

6.  Antibody reactivity with HBLV (HHV-6) in U.S. populations.

Authors:  C Saxinger; H Polesky; N Eby; S Grufferman; R Murphy; G Tegtmeir; V Parekh; S Memon; C Hung
Journal:  J Virol Methods       Date:  1988-09       Impact factor: 2.014

7.  Seroepidemiology of human herpesvirus 6 infection in normal children and adults.

Authors:  T Okuno; K Takahashi; K Balachandra; K Shiraki; K Yamanishi; M Takahashi; K Baba
Journal:  J Clin Microbiol       Date:  1989-04       Impact factor: 5.948

8.  Human herpes virus type 6 (HHV-6) and its in vitro effect on human immunodeficiency virus (HIV).

Authors:  G R Pietroboni; G B Harnett; T J Farr; M R Bucens
Journal:  J Clin Pathol       Date:  1988-12       Impact factor: 3.411

9.  Identification of human herpesvirus-6 as a causal agent for exanthem subitum.

Authors:  K Yamanishi; T Okuno; K Shiraki; M Takahashi; T Kondo; Y Asano; T Kurata
Journal:  Lancet       Date:  1988-05-14       Impact factor: 79.321

10.  Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders.

Authors:  S Z Salahuddin; D V Ablashi; P D Markham; S F Josephs; S Sturzenegger; M Kaplan; G Halligan; P Biberfeld; F Wong-Staal; B Kramarsky
Journal:  Science       Date:  1986-10-31       Impact factor: 47.728
View more
  2 in total

Review 1.  Human herpesvirus 6.

Authors:  D K Braun; G Dominguez; P E Pellett
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Detection of viral DNA and immune responses to the human herpesvirus 6 101-kilodalton virion protein in patients with multiple sclerosis and in controls.

Authors:  Maria V Tejada-Simon; Ying C Q Zang; Jian Hong; Victor M Rivera; James M Killian; Jingwu Z Zhang
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.